Heron Therapeutics reported $-61015000 in Pre-Tax Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Alexion Pharmaceuticals ALXN:US $ 940.1M 164.6M
Alnylam Pharmaceuticals ALNY:US $ -188.33M 10.94M
Amarin AMRN:US $ 8.87M 9.87M
Ani Pharmaceuticals ANIP:US $ 11.04M 5.43M
Anika Therapeutics ANIK:US $ 9.13M 7.92M
Arrowhead Research ARWR:US $ -29.92M 3.11M
Eisai 4523:JP Y 55783M 61588M
Endo International Ordinary Shares ENDP:US $ 181.61M 22.56M
Esperion Therapeutics ESPR:US $ -43668000 47.27M
Flexion Therapeutics FLXN:US $ -22208000 6.35M
GlaxoSmithKline GSK:LN 1482M 225M
Heron Therapeutics HRTX:US $ -61.02M 8.4M
Immunogen IMGN:US $ -30.74M 3.31M
Insmed INSM:US $ -116699000 25.3M
Ligand Pharmaceuticals LGND:US $ 34.99M 4.55M
Nektar Therapeutics NKTR:US $ -125.16M 3.89M
Neurocrine Biosciences NBIX:US $ 57.5M 30.3M
Omeros OMER:US $ -28593000 6.5M
Regeneron Pharmaceuticals REGN:US $ 3898.3M 2658.7M
Sangamo Biosciences SGMO:US $ -47.15M 1.47M
Ultragenyx Pharmaceutical RARE:US $ -121.96M 13.8M
Veracyte VCYT:US $ 9.19M 19.75M
Zogenix ZGNX:US $ -58.9M 3.27M